Talat Imran
2023
In 2023, Talat Imran earned a total compensation of $5.3M as Chief Executive Officer at Rani Therapeutics Holdings, a 22% increase compared to previous year.
Compensation breakdown
| Option Awards | $2,893,853 |
|---|---|
| Salary | $450,000 |
| Stock Awards | $1,923,040 |
| Total | $5,266,893 |
Imran received $2.9M in option awards, accounting for 55% of the total pay in 2023.
Imran also received $450K in salary and $1.9M in stock awards.
Rankings
In 2023, Talat Imran's compensation ranked 107th out of 3,006 executives tracked by ExecPay. In other words, Imran earned more than 96.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 107 out of 3,006 | 96th |
Division Manufacturing | 60 out of 1,650 | 96th |
Major group Chemicals And Allied Products | 36 out of 918 | 96th |
Industry group Drugs | 35 out of 881 | 96th |
Industry Pharmaceutical Preparations | 24 out of 637 | 96th |
Source: SEC filing on April 17, 2024.
Imran's colleagues
We found two more compensation records of executives who worked with Talat Imran at Rani Therapeutics Holdings in 2023.